Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

被引:39
作者
Lin, Richard J. [1 ]
Elko, Theresa A. [1 ]
Devlin, Sean M. [2 ]
Shahrokni, Armin [3 ,4 ]
Jakubowski, Ann A. [1 ,4 ]
Dahi, Parastoo B. [1 ,4 ]
Perales, Miguel-Angel [1 ,4 ]
Tamari, Roni [1 ,4 ]
Shaffer, Brian C. [1 ,4 ]
Sauter, Craig S. [1 ,4 ]
Papadopoulos, Esperanza B. [1 ,4 ]
Gyurkocza, Boglarka [1 ,4 ]
Korc-Grodzicki, Beatriz [3 ,4 ]
Barker, Juliet N. [1 ,4 ]
Maloy, Molly A. [1 ]
Giralt, Sergio A. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult BMT Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Geriatr Serv, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; COMORBIDITY INDEX; RISK-ASSESSMENT; SURVIVAL; AGE; VALIDATION; FERRITIN; ALBUMIN;
D O I
10.1038/s41409-019-0654-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR=1.82; 95% CI, 1.04-3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 28 条
  • [1] Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
    Armand, Philippe
    Kim, Haesook T.
    Logan, Brent R.
    Wang, Zhiwei
    Alyea, Edwin P.
    Kalaycio, Matt E.
    Maziarz, Richard T.
    Antin, Joseph H.
    Soiffer, Robert J.
    Weisdorf, Daniel J.
    Rizzo, J. Douglas
    Horowitz, Mary M.
    Saber, Wael
    [J]. BLOOD, 2014, 123 (23) : 3664 - 3671
  • [2] Biologic vs physiologic age in the transplant candidate
    Artz, Andrew S.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 99 - 105
  • [3] The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
    Artz, Andrew S.
    Logan, Brent
    Zhu, Xiaochun
    Akpek, Gorgun
    Martino Bufarull, Rodrigo
    Gupta, Vikas
    Lazarus, Hillard M.
    Litzow, Mark
    Loren, Alison
    Majhail, Navneet S.
    Maziarz, Ric Hard T.
    McCarthy, Philip
    Popat, Uday
    Saber, Wael
    Spellman, Stephen
    Ringden, Olle
    Wickrema, Amittha
    Pasquini, Marcelo C.
    Cooke, Kenneth R.
    [J]. HAEMATOLOGICA, 2016, 101 (11) : 1426 - 1433
  • [4] Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation
    Bejanyan, Nelli
    Brunstein, Claudio G.
    Cao, Qing
    Lazaryan, Aleksandr
    Ustun, Celalettin
    Warlick, Erica D.
    Arora, Mukta
    Wagner, John E.
    Weisdorf, Daniel J.
    [J]. BLOOD ADVANCES, 2019, 3 (03) : 230 - 236
  • [5] D'Souza A., 2017, Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides
  • [6] Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis
    Deschler, Barbara
    Ihorst, Gabriele
    Schnitzler, Susanne
    Bertz, Hartmut
    Finke, Juergen
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (05) : 565 - 575
  • [7] Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies
    DuMontier, Clark
    Liu, Michael A.
    Murillo, Anays
    Hshieh, Tammy
    Javedan, Houman
    Soiffer, Robert
    Stone, Richard M.
    Driver, Jane A.
    Abel, Gregory A.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (05) : 889 - 897
  • [8] Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation
    Elsawy, M.
    Sorror, M. L.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1283 - 1300
  • [9] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Fein, Joshua A.
    Shimoni, Avichai
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Magen, Hila
    Furie, Nadav
    Kopel, Eli
    Danylesko, Ivetta
    Nagler, Arnon
    Shouval, Roni
    [J]. LEUKEMIA, 2018, 32 (08) : 1787 - 1794
  • [10] Giralt SA, 2017, HDB GERIATRICS ONCOL, P241